vTv Therapeutics Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
VTVT Nasdaq 2836 vtvtherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for vTv Therapeutics Inc.

vTv Therapeutics Inc. (NASDAQ:VTVT) Just Beat Earnings: Here's What Analysts Think Will Happen Next - May 17th, 2026 7:26 am
vTv Therapeutics (VTVT) is on the Move, Here's Why the Trend Could be Sustainable - May 15th, 2026 6:55 am
vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - May 13th, 2026 2:01 pm
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - May 8th, 2026 2:15 pm
vTv Therapeutics to Participate in Upcoming May Investor Conferences - May 7th, 2026 6:00 am
Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High? - Apr 20th, 2026 7:55 am
Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet - Apr 2nd, 2026 7:55 am
vTv Therapeutics (VTVT) Reports $27M 2025 Net Loss Amid Cadisegliatin Advancements - Mar 17th, 2026 6:05 pm
Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade - Mar 17th, 2026 7:55 am
vTv Therapeutics to Participate in the 38th Annual ROTH Conference - Mar 16th, 2026 6:00 am
VTv Therapeutics: Q4 Earnings Snapshot - Mar 10th, 2026 2:17 pm
vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - Mar 10th, 2026 2:01 pm
vTv Therapeutics (VTVT) Secures Global Partnership for PDE4 Inhibitor HPP737 - Mar 3rd, 2026 10:11 pm
vTv Therapeutics to Participate in Upcoming Investor Conferences - Feb 13th, 2026 6:00 am
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737 - Feb 2nd, 2026 6:00 am
An Alzheimer’s Drug Could Supercharge This High-Risk Stock. Is It Worth a Buy Here? - Jan 5th, 2026 9:40 am
vTv Therapeutics (VTVT) Upgraded to Buy: Here's What You Should Know - Dec 24th, 2025 10:00 am
We're Interested To See How vTv Therapeutics (NASDAQ:VTVT) Uses Its Cash Hoard To Grow - Dec 19th, 2025 7:18 am
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health - Dec 18th, 2025 2:05 pm
All You Need to Know About vTv Therapeutics (VTVT) Rating Upgrade to Buy - Nov 11th, 2025 10:00 am